A detailed history of Keynote Financial Services LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Keynote Financial Services LLC holds 27,186 shares of ABT stock, worth $3.2 Million. This represents 2.37% of its overall portfolio holdings.

Number of Shares
27,186
Previous 27,491 1.11%
Holding current value
$3.2 Million
Previous $2.86 Billion 8.5%
% of portfolio
2.37%
Previous 2.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$100.07 - $118.13 $30,521 - $36,029
-305 Reduced 1.11%
27,186 $3.1 Billion
Q2 2024

Jul 24, 2024

BUY
$100.73 - $112.44 $8,058 - $8,995
80 Added 0.29%
27,491 $2.86 Billion
Q1 2024

Jun 13, 2024

BUY
$109.52 - $120.96 $3 Million - $3.32 Million
27,411 New
27,411 $3.12 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Keynote Financial Services LLC Portfolio

Follow Keynote Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keynote Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keynote Financial Services LLC with notifications on news.